[Featured Stock] Antiphos Rises 10% on News of COVID-19 Antigen Rapid Test Kit Export Approval

[Asia Economy Reporter Minji Lee] AndyForce is on the rise following news that it has obtained export approval from the Ministry of Food and Drug Safety (MFDS) for its COVID-19 antigen rapid diagnostic kit.

At 9:28 a.m. on the 16th, AndyForce was trading at 9,490 KRW on the KOSDAQ market, up 9.84% from the previous session.

Earlier that morning, AndyForce announced that after receiving European certification (CE) for its antigen rapid diagnostic kit in September, it has now obtained export approval domestically. The company plans to pursue approval from the U.S. Food and Drug Administration (FDA) in the future.